On the occasion of World AIDS Day 2022, MPP ED Charles Gore announces that WHO’s preferred first-line HIV treatment is now available through our generic partners in over 100 countries and that 20 million people living with HIV are on this treatment.

He also talks about how there is still a big health gap, in particular the number of new HIV infections every year.

“MPP’s recent licence agreement on long-acting pre-exposure prophylaxis drug cabotegravir will potentially be a game changer in preventing these new infections.”


#WorldAIDSDay 2022 ?? Message from MPP’s generic manufacturing partners

#WorldAIDSDay message from the people of Desmond Tutu Health Foundation, #SouthAfrica